当前位置:首页 - 行情中心 - 奇正藏药(002287) - 财务分析 - 资产负债表

奇正藏药

(002287)

  

流通市值:120.19亿  总市值:120.46亿
流通股本:5.29亿   总股本:5.30亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金403,434,169.14223,908,002.02590,089,839.54155,140,504.55
应收票据及应收账款75,803,741.72201,365,941.93277,321,327.57174,784,074.99
其中:应收票据--115,710211,470
应收账款75,803,741.72201,365,941.93277,205,617.57174,572,604.99
应收款项融资529,054,005.83610,837,919.6307,396,699.45653,837,986.61
预付款项6,904,746.3121,744,651.1917,971,807.337,151,090.27
其他应收款合计18,337,194.1367,524,030.5259,556,598.4840,633,106.39
存货156,332,923.24163,819,738.01153,663,560.45154,854,607.47
其他流动资产41,454,626.7123,545,624.5921,119,080.9424,496,815.67
流动资产平衡项目0000
流动资产合计3,194,367,199.443,361,608,944.363,837,741,804.353,221,184,858.24
非流动资产:
长期股权投资61,005,521.74305,952,546.66345,932,139.8532,164,997.8
其他非流动金融资产626,595,018.81634,420,000644,060,000637,460,000
投资性房地产13,392,298.5620,676,046.4721,662,569.0222,150,641.99
固定资产1,330,142,802.78577,722,653.71580,436,623.76589,915,949.93
在建工程302,750,232.16731,728,262.74661,590,138.89558,388,508.59
使用权资产14,438,610.988,558,666.89,011,375.7812,610,952.9
无形资产351,617,883.11354,892,768.64361,490,412.14368,148,924.98
长期待摊费用4,948,114.024,541,373.142,830,899.752,864,698.78
递延所得税资产39,389,13136,077,792.8230,245,837.0432,062,811.39
其他非流动资产359,831,780.98358,890,300.612,027,740.097,027,820.02
非流动资产平衡项目0000
非流动资产合计3,104,111,394.143,033,460,411.592,659,287,736.272,762,795,306.38
资产平衡项目0000
资产总计6,298,478,593.586,395,069,355.956,497,029,540.625,983,980,164.62
流动负债:
短期借款451,518,361.121,050,442,177.781,003,534,652.77702,517,638.89
应付票据及应付账款266,234,127.49120,864,837.32120,709,404.5686,270,834.82
其中:应付票据10,631,055.5749,656,883.955,021,529.5735,534,187.57
应付账款255,603,071.9271,207,953.4265,687,874.9950,736,647.25
合同负债73,889,040.3550,880,242.764,166,219.2253,095,039.19
应付职工薪酬135,174,658.9549,901,859.1174,593,054.71102,473,605.45
应交税费103,526,902.5154,881,629.3560,583,968.2838,774,053.46
其他应付款合计196,589,013.53191,430,637.51385,664,632.53200,884,924.35
应付股利2,564,131.162,618,960.41209,095,167.492,320,537.48
一年内到期的非流动负债15,413,069.298,513,375.8816,098,181.1162,695,952.79
其他流动负债2,872,299.231,684,639.868,153,641.73581,135.53
流动负债平衡项目0000
流动负债合计1,245,217,472.471,528,599,399.511,733,503,754.911,247,293,184.48
非流动负债:
长期借款281,287,821.43286,887,821.43286,887,821.43286,887,821.43
应付债券779,987,699.03771,176,700.27761,564,963.4752,518,510.24
租赁负债6,995,877.093,650,419.194,339,731.584,927,807.69
长期应付款2,600,0002,600,0002,600,0002,600,000
递延收益191,304,725.83200,780,315.19171,470,315.19174,039,162.98
递延所得税负债20,940,904.0839,781,755.6643,249,177.6536,279,432.82
非流动负债平衡项目0000
非流动负债合计1,283,117,027.461,304,877,011.741,270,112,009.251,257,252,735.16
负债平衡项目0000
负债合计2,528,334,499.932,833,476,411.253,003,615,764.162,504,545,919.64
所有者权益(或股东权益):
实收资本(或股本)530,192,538530,192,452530,191,359530,190,974
其他权益工具134,246,948.53133,933,084.67134,043,796.26133,651,381.77
资本公积477,249,612.15475,723,213.28476,352,872.98476,536,120.33
减:库存股480,875.978,185,041.918,185,041.918,185,041.91
其他综合收益1,808,470.42,314,321.362,549,392.47734,185.36
专项储备1,192,138.631,136,244.221,104,211.41614,918.49
盈余公积471,975,827.78416,944,483.56416,944,483.56416,944,483.56
未分配利润2,104,144,112.941,958,528,576.791,890,294,862.71,877,565,503.36
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,720,328,772.463,510,587,333.973,443,295,936.473,428,052,524.96
少数股东权益49,815,321.1951,005,610.7350,117,839.9951,381,720.02
股东权益平衡项目0000
股东权益合计3,770,144,093.653,561,592,944.73,493,413,776.463,479,434,244.98
负债和股东权益合计6,298,478,593.586,395,069,355.956,497,029,540.625,983,980,164.62
公告日期2024-04-192023-10-272023-08-252023-04-28
审计意见(境内)标准无保留意见
TOP↑